Markets SRTS

Thursday 9/3 Insider Buying Report: SRTS, DY

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At Sensus Healthcare, a filing with the SEC revealed that on Monday, Eric Sachetta purchased 64,841 shares of SRTS, for a cost of $3.48 each, for a total investment of $225,616. Bargain hunters have the opportunity to pick up SRTS at a price even lower than Sachetta did, with shares changing hands as low as $3.14 in trading on Thursday which is 9.7% under Sachetta's purchase price. Sensus Healthcare is trading off about 0.9% on the day Thursday. Before this latest buy, Sachetta purchased SRTS on 5 other occasions during the past twelve months, for a total investment of $293,689 at an average of $3.25 per share.

And at Dycom Industries, there was insider buying on Tuesday, by David Joseph Fallon who bought 700 shares for a cost of $286.92 each, for a total investment of $200,844. This buy marks the first one filed by Fallon in the past twelve months. Dycom Industries is trading off about 0.4% on the day Thursday. So far Fallon is in the green, up about 4.4% on their purchase based on today's trading high of $299.61.

Thursday 9/3 Insider Buying Report: SRTS, DY   VIDEO: Thursday 9/3 Insider Buying Report: SRTS, DY

BNK Invest
BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.
10 Bargains You Can Buy Cheaper Than Insiders Did 10 Stocks Crossing Below Book Value 10 Oversold Stocks You Need To Know About More articles by this source
Stocks Mentioned

Latest Articles

Data is currently not available